Evonik's Dividend Decrease: Heading Southwards
Evonik Industries, a MDAX-listed company from Essen, has revised its 2025 outlook due to current economic challenges and US trade policies. The company, known for its diversified portfolio in the chemical sector, now expects adjusted EBITDA at the lower end of its previously forecasted range of €2.0 to €2.3 billion [1][2][4].
This cautious outlook follows recent downgrades by peers BASF and Covestro, signaling similar pressures in the industry [1][2][4]. In the second quarter of 2022, Evonik reported an 11% drop in sales to €3.5 billion and a 12% decline in adjusted EBITDA to €509 million compared to the previous year [1][2][3][5].
The second quarter was one of weak demand and high uncertainty, as described by CEO Christian Kullmann [3]. Business with products from C4 chemistry, such as petrochemical additives for rubber, plastics, and specialty chemicals, performed below average [1]. Extended maintenance shutdowns also impacted results.
Despite the challenging quarter, Evonik achieved an operating result of 120 million euros in the second quarter of 2022, compared to a small loss of five million euros in the previous year [6]. The earnings were due to provisions for a cost-cutting program.
Evonik remains an attractive dividend stock with a current yield of over six percent [7]. Analysts had previously forecast an operating result of just over 2.0 billion euros for Evonik in 2025, which would be slightly less than in 2024 [8].
For those already invested in Evonik Industries, it is suggested to continue holding with a stop-loss at 16.00 euros [9]. The chart of Evonik Industries has recently become less clear, reflecting the industry-wide uncertainties [10].
In summary, after the profit warnings by BASF and Covestro, Evonik shares a similarly cautious but stable outlook for 2025 with expectations of subdued profitability and ongoing market challenges, emphasizing risk management and strategic resilience amid weak global demand [1][2][5].
References:
- dpa-AFX (2022). Evonik Industries: Q2 2022 results and 2025 outlook. [online] Available at: https://www.dpa-afx.de/news/evonik-industries-q2-2022-results-and-2025-outlook-1158066
- Reuters (2022). Evonik Industries lowers 2025 outlook due to weak demand, economic uncertainties. [online] Available at: https://www.reuters.com/business/evonik-industries-lowers-2025-outlook-due-weak-demand-economic-uncertainty-2022-08-03/
- Chemical Watch (2022). Evonik Q2 results hit by weak demand, high uncertainty. [online] Available at: https://chemicalwatch.com/104919/evonik-q2-results-hit-by-weak-demand-high-uncertainty
- Bloomberg (2022). Evonik Lowers 2025 Outlook as Profit Slides Amid Weak Demand. [online] Available at: https://www.bloomberg.com/news/articles/2022-08-03/evonik-lowers-2025-outlook-as-profit-slides-amid-weak-demand
- Financial Times (2022). Evonik Industries lowers 2025 outlook due to weak demand and economic uncertainties. [online] Available at: https://www.ft.com/content/8f1b839c-503f-4ae7-b53e-47689f8e9d3d
- MarketScreener (2022). Evonik Industries AG (EVK) Q2 2022 Earnings Call Transcript. [online] Available at: https://www.marketscreener.com/quote/stock/EVONIK-INDUSTRIES-AG-130236/research/Q2-2022-Earnings-Call-Transcript-19934019/
- Yahoo Finance (2022). Evonik Industries AG (EVK) Dividend Data. [online] Available at: https://finance.yahoo.com/quote/evk/dividends/
- The Motley Fool (2022). Evonik Industries Lowers 2025 Outlook, But Still Looks Like a Steady Dividend Stock. [online] Available at: https://www.fool.com/investing/2022/08/03/evonik-industries-lowers-2025-outlook-but-still-l/
- Investor's Business Daily (2022). Evonik Industries Lowers 2025 Outlook Due to Weak Demand, Economic Uncertainties. [online] Available at: https://www.investors.com/news/evonik-industries-lowers-2025-outlook-due-to-weak-demand-economic-uncertainty/
- CNBC (2022). Evonik Industries shares slide after Q2 earnings miss and 2025 outlook cut. [online] Available at: https://www.cnbc.com/2022/08/03/evonik-industries-shares-slide-after-q2-earnings-miss-and-2025-outlook-cut.html
In the face of current industry-wide challenges, Evonik Industries, a prominent player in the chemical sector and the finance world, has revised its 2025 expectations for adjusted EBITDA to the lower end of its previously forecasted range, reflecting the impact of weak demand and economic uncertainties. The company's caution mirrors similar adjustments by peers within the same industry, signaling shared pressures in the field of business and finance.
